The changing profile of idiopathic myelofibrosis: A comparison of the presenting features of patients diagnosed in two different decades

European Journal of Haematology

Volumn 60, Issue 2, 1998, Pages 101-105

  Cervantes, Francisco ^a,b   Pereira, Arturo ^a   Esteve, Jordi ^a   Cobo, Francesc ^a   Rozman, Ciril ^a   Montserrat, Emilio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Clinicohematological features; Idiopathic myelofibrosis

Indexed keywords

ALPHA INTERFERON; ANDROGEN; BUSULFAN; CYCLOPHOSPHAMIDE; ERYTHROPOIETIN; HYDROXYUREA; MERCAPTOPURINE; PREDNISONE; VITAMIN D DERIVATIVE;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; FEMALE; FEVER; HEPATOMEGALY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOFIBROSIS; ORAL DRUG ADMINISTRATION; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; SPLENECTOMY; SPLENOMEGALY; SURVIVAL RATE; SWEATING; SYMPTOMATOLOGY; TIME; WEIGHT REDUCTION;

EID: 0031916326     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01005.x     Document Type: Article

References (20)

1. JACOBSON RJ, SALO A, FIALKOW PJ. Agnogenic myeloid metaplasia: a clonal proliferation of hemopoietic stem cells with secondary myelofibrosis. Blood 1978: 15: 189-194.
2. BOURONCLE B, DOAN CA. Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients. Am J Clin Sci 1962: 243: 697-715.
3. WARD HP, BLOCK MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1971: 50: 357-420.
4. SILVERSTEIN MN, GOMES NR, REMINE WH, ELVEBACK LR. Agnogenic myeloid metaplasia: natural history and treatment. Arch Intern Med 1967: 120: 546-550.
5. HASSELBACH H. Idiopathic myelofibrosis: a review. Eur J Haematol 1990: 45: 65-72.
6. RUPOLI S, DA LIO L, SISTI S, CAMPANATI G, SALVI A, BRIANZONI MF. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival. Ann Hematol 1994: 68: 205-212.
7. THIELE J, KVASNICKA HJ, WERDEN C, ZANCOVICH R, DIEHL V, FISCHER R. Idiopathic primary osteo-myelofibrosis: a clinicopathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymph 1996: 22: 303-317.
8. BAROSI G, BERZUINI C, LIBERATO LN, COSTA A, POLINO G, ASCARI E. A prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 1988: 70: 397-401.
9. HASSELBACH H. Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol 1990: 34: 291-300.
10. ITALIAN COOPERATIVE STUDY GROUP ON CHRONIC MYELOID LEUKEMIA. Prospective confirmation of a prognostic classification of Ph+ chronic myeloid leukemia: the value of early evaluation of the course of the disease. Ann Hematol 1991: 63: 307-314.
11. PEARSON TC. Primary thrombocythaemia: diagnosis and management. Br J Haematol 1991: 78: 145-148.
12. PEREIRA A, CERVANTES F, BRUGUÉS R, ROZMAN C. Bone marrow histopathology in primary myelofibrosis: clinical and haematologic correlations and prognostic evaluation. Eur J Haematol 1990: 44: 94-98.
13. LENNERT K, NAGHAI K, SCHWARZE EW. Patho-anatomical features of the bone marrow. Clin Haematol 1975: 4: 331-351.
14. KAPLAN GL, MEIER P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958: 53: 457-480.
15. MANTEL N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966: 50: 163-170.
16. CERVANTES F, PEREIRA A, ESTEVE J, et al. Identification of "short-lived" and "long-lived" patients at presentation of idiopathic myelofibrosis. Br J Haematol 1997: 97: 635-640.
17. DUPRIEZ B, MOREL P, DEMORY JL, et al. Prognostic factors in agnogeneic myeloid metaplasia: a report on 195 cases with a new scoring system. Blood 1996: 88: 1013-1018.
18. VARKI A, LOTTENBERG R, GRIFFITH R, REINHARD E. The syndrome of idiopathic myelofibrosis: a clinicopathological review with emphasis on the prognostic variables predicting survival. Medicine 1983: 62: 353-371.
19. VISANI G, FINELLI C, CASTELLI U, PETTI MC, RICCI P, VIANELLI N. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol 1990: 75: 4-9.
20. DEMORY JL, DUPRIEZ B, FENAUX P, et al. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood 1988: 72: 855-859.